146 related articles for article (PubMed ID: 38375454)
1. Therapeutic effects and underlying mechanism of poly (L-glutamic acid)-
Chen J; Yin M; Yang C; Wang K; Ma L; Yu H; Huang Y; Liu F; Tang Z
Front Bioeng Biotechnol; 2024; 12():1336692. PubMed ID: 38375454
[No Abstract] [Full Text] [Related]
2. Formula optimization and in vivo study of poly(L-glutamic acid)-g-methoxy poly(ethylene glycol)/combretastatin A4/BLZ945 nanoparticles for cancer therapy.
Huang Y; Yang C; Lv J; Zhang Y; Wang K; Ma L; Liu Z; Yu H; Li M; Tang Z
Int J Pharm; 2023 Apr; 636():122849. PubMed ID: 36933582
[TBL] [Abstract][Full Text] [Related]
3. Preparation and Characterization Evaluation of Poly(L-Glutamic Acid)-
Guo D; Huang Y; Wang K; Yang C; Ma L; Zhang Y; Yu H; Cui M; Tang Z
Int J Nanomedicine; 2023; 18():6901-6914. PubMed ID: 38026524
[TBL] [Abstract][Full Text] [Related]
4. FXIIIa substrate peptide decorated BLZ945 nanoparticles for specifically remodeling tumor immunity.
Wei Q; Shen N; Yu H; Wang Y; Tang Z; Chen X
Biomater Sci; 2020 Oct; 8(20):5666-5676. PubMed ID: 33049011
[TBL] [Abstract][Full Text] [Related]
5. Co-administration of combretastatin A4 nanoparticles and sorafenib for systemic therapy of hepatocellular carcinoma.
Wang Y; Yu H; Zhang D; Wang G; Song W; Liu Y; Ma S; Tang Z; Liu Z; Sakurai K; Chen X
Acta Biomater; 2019 Jul; 92():229-240. PubMed ID: 31100462
[TBL] [Abstract][Full Text] [Related]
6. Enhanced anti-PD-1 therapy in hepatocellular carcinoma by tumor vascular disruption and normalization dependent on combretastatin A4 nanoparticles and DC101.
Bao X; Shen N; Lou Y; Yu H; Wang Y; Liu L; Tang Z; Chen X
Theranostics; 2021; 11(12):5955-5969. PubMed ID: 33897892
[TBL] [Abstract][Full Text] [Related]
7. Co-administration of combretastatin A4 nanoparticles and anti-PD-L1 for synergistic therapy of hepatocellular carcinoma.
Zhao B; Dong Z; Liu W; Lou F; Wang Q; Hong H; Wang Y
J Nanobiotechnology; 2021 May; 19(1):124. PubMed ID: 33933077
[TBL] [Abstract][Full Text] [Related]
8. Poly(L-Glutamic Acid)-Drug Conjugates for Chemo- and Photodynamic Combination Therapy.
Yu H; Bao Y; Xu C; Chen L; Tang Z
Macromol Biosci; 2021 Jan; 21(1):e2000192. PubMed ID: 33043592
[TBL] [Abstract][Full Text] [Related]
9. A poly(l-glutamic acid)-combretastatin A4 conjugate for solid tumor therapy: Markedly improved therapeutic efficiency through its low tissue penetration in solid tumor.
Liu T; Zhang D; Song W; Tang Z; Zhu J; Ma Z; Wang X; Chen X; Tong T
Acta Biomater; 2017 Apr; 53():179-189. PubMed ID: 28167300
[TBL] [Abstract][Full Text] [Related]
10. Combretastatin A4/poly(
Ou Y; Tang ZH; Sun L; Yu HY; Li J; Zhao MH; Xu H
Asian J Pharm Sci; 2018 Mar; 13(2):191-196. PubMed ID: 32104392
[TBL] [Abstract][Full Text] [Related]
11. PI3Kgamma Inhibitor Attenuates Immunosuppressive Effect of Poly(l-Glutamic Acid)-Combretastatin A4 Conjugate in Metastatic Breast Cancer.
Qin H; Yu H; Sheng J; Zhang D; Shen N; Liu L; Tang Z; Chen X
Adv Sci (Weinh); 2019 Jun; 6(12):1900327. PubMed ID: 31380170
[TBL] [Abstract][Full Text] [Related]
12. A UHPLC-MS/MS method coupled with simple and efficient alkaline hydrolysis for free and total determination of conjugate nanomedicine: Pharmacokinetic and biodistribution study of poly (l-glutamic acid)-graft-methoxy poly (ethylene glycol)/combretastatin A4.
Zeng Q; Liu Y; Song Y; Feng B; Xu P; Shan B; Liao Z; Liu K; Zhong Y; Chen L; Su D
J Pharm Biomed Anal; 2019 May; 169():215-224. PubMed ID: 30877933
[TBL] [Abstract][Full Text] [Related]
13. Tumor regression and potentiation of polymeric vascular disrupting therapy through reprogramming of a hypoxia microenvironment with temsirolimus.
Yu H; Shen N; Bao Y; Chen L; Tang Z
Biomater Sci; 2020 Jan; 8(1):325-332. PubMed ID: 31714543
[TBL] [Abstract][Full Text] [Related]
14. Combretastatin A4 Nanoparticles Combined with Hypoxia-Sensitive Imiquimod: A New Paradigm for the Modulation of Host Immunological Responses during Cancer Treatment.
Shen N; Wu J; Yang C; Yu H; Yang S; Li T; Chen J; Tang Z; Chen X
Nano Lett; 2019 Nov; 19(11):8021-8031. PubMed ID: 31558024
[TBL] [Abstract][Full Text] [Related]
15. Combretastatin A4 Regulates Proliferation, Migration, Invasion, and Apoptosis of Thyroid Cancer Cells via PI3K/Akt Signaling Pathway.
Liang W; Lai Y; Zhu M; Huang S; Feng W; Gu X
Med Sci Monit; 2016 Dec; 22():4911-4917. PubMed ID: 27966519
[TBL] [Abstract][Full Text] [Related]
16. Combretastatin A4-loaded Poly (Lactic-co-glycolic Acid)/Soybean Lecithin Nanoparticles with Enhanced Drug Dissolution Rate and Antiproliferation Activity.
Cao Y; Ahmed AMQ; Du HH; Sun W; Lu X; Xu Z; Tao J; Cao QR
Curr Drug Deliv; 2022 Aug; 19(9):918-927. PubMed ID: 35139789
[TBL] [Abstract][Full Text] [Related]
17. Cisplatin-loaded polymeric nanoparticles: characterization and potential exploitation for the treatment of non-small cell lung carcinoma.
Shi C; Yu H; Sun D; Ma L; Tang Z; Xiao Q; Chen X
Acta Biomater; 2015 May; 18():68-76. PubMed ID: 25707922
[TBL] [Abstract][Full Text] [Related]
18. Water-Soluble Combretastatin A4 Phosphate Orally Delivered via Composite Nanoparticles With Improved Inhibition Effect Toward S180 Tumors.
Shen Y; Wu L; Qiu L
J Pharm Sci; 2017 Oct; 106(10):3076-3083. PubMed ID: 28619603
[TBL] [Abstract][Full Text] [Related]
19. Cabozantinib-Loaded PLGA Nanoparticles: A Potential Adjuvant Strategy for Surgically Resected High-Risk Non-Metastatic Renal Cell Carcinoma.
Lee HW; Seo HS; Yeom SY; Kim SN; Kim CR; Park DH; Park W; Choy YB; Park CG; Seo SI
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293494
[TBL] [Abstract][Full Text] [Related]
20. Cisplatin Loaded Poly(L-glutamic acid)-g-Methoxy Polyethylene Glycol Complex Nanoparticles Combined with Gemcitabine Presents Improved Safety and Lasting Anti-Tumor Efficacy in a Murine Xenograft Model of Human Aggressive B Cell Lymphoma.
Liu Z; Wang S; Guo W; Zhang D; Yu H; Song W; Tang Z; Bai O
J Biomed Nanotechnol; 2021 Apr; 17(4):652-661. PubMed ID: 35057891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]